Ledger.Open graph →
SEC Form D · filed October 20, 2025

Vergent Bioscience, Inc

Offering
$32.0M
Sold
$18.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MINNEAPOLIS, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Raymond T. Wong · Minneapolis, MNDirectorJeffrey T. Yurecko · Minneapolis, MNExecAnita T. Watkins · Minneapolis, MNDirectorBobby T. Helmedag · Minneapolis, MNDirectorDouglas T. Kohrs · Minneapolis, MNDirectorBobby T. Helmedag · Minneapolis, MNDirectorAnita T. Watkins · Minneapolis, MNDirectorDouglas T. Kohrs · Minneapolis, MNDirectorJeffrey T. Yurecko · Minneapolis, MNExecRaymond T. Wong · Minneapolis, MNDirectorJohn T. Santini, Jr · Menlo Park, CAExec · DirectorNancy T. Chang · Malvern, PADirectorJ. M. Sorensen · Malvern, PADirectorAndrew Rigby · Holladay, UTExecMichael R. Friedman · Malvern, PADirectorJoel M. Sussman · Malvern, PADirectorJohn T. Santini, Jr · Minneapolis, MNExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗